155 related articles for article (PubMed ID: 38663378)
1. [Not Available].
Schäfer JF
Rofo; 2024 May; 196(5):422-423. PubMed ID: 38663378
[No Abstract] [Full Text] [Related]
2. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
Platzek I
PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography-magnetic resonance imaging in the evaluation of brain tumors: current status and future prospects.
Nguyen N; Montagnese J; Rogers LR; Sher A; Wolansky L
Semin Roentgenol; 2014 Jul; 49(3):275-89. PubMed ID: 25497912
[No Abstract] [Full Text] [Related]
4. Speeding up PET/MR for cancer staging of children and young adults.
Aghighi M; Pisani LJ; Sun Z; Klenk C; Madnawat H; Fineman SL; Advani R; Von Eyben R; Owen D; Quon A; Moseley M; Daldrup-Link HE
Eur Radiol; 2016 Dec; 26(12):4239-4248. PubMed ID: 27048532
[TBL] [Abstract][Full Text] [Related]
5. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
6. [
Jannusch K; Morawitz J; Schweiger B; Weiss D; Schimmöller L; Minko P; Herrmann K; Fendler WP; Quick HH; Antoch G; Umutlu L; Kirchner J; Bruckmann NM
Eur Radiol; 2023 Nov; 33(11):8366-8375. PubMed ID: 37338559
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of whole-body magnetic resonance imaging versus positron emission tomography-computed tomography for the staging of pediatric lymphoma: a systematic review and meta-analysis.
Bhalla D; Jana M; Kandasamy D
Pediatr Radiol; 2023 Dec; 53(13):2683-2691. PubMed ID: 37814104
[TBL] [Abstract][Full Text] [Related]
8. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
9. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
10. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
Platzek I; Beuthien-Baumann B; Ordemann R; Maus J; Schramm G; Kitzler HH; Laniado M; Kotzerke J; van den Hoff J
Acad Radiol; 2014 Oct; 21(10):1314-9. PubMed ID: 25086953
[TBL] [Abstract][Full Text] [Related]
12.
Ferdová E; Ferda J; Baxa J
Eur J Radiol; 2017 Sep; 94():A52-A63. PubMed ID: 28132716
[TBL] [Abstract][Full Text] [Related]
13. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Platzek I
PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
[TBL] [Abstract][Full Text] [Related]
14. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
[TBL] [Abstract][Full Text] [Related]
16. PET/computed tomography and lymphoma.
Allen-Auerbach M; de Vos S; Czernin J
Radiol Clin North Am; 2013 Sep; 51(5):833-44. PubMed ID: 24010908
[TBL] [Abstract][Full Text] [Related]
17. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Albano D; Patti C; La Grutta L; Agnello F; Grassedonio E; Mulè A; Cannizzaro G; Ficola U; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2016 Feb; 85(2):313-8. PubMed ID: 26781135
[TBL] [Abstract][Full Text] [Related]
18. Detecting marrow involvement in lymphoma: Can-
Kaushik P; Tripathi M
Indian J Med Res; 2021 May; 154(5):658-660. PubMed ID: 35532582
[No Abstract] [Full Text] [Related]
19. Lung cancer: positron emission tomography/computed tomography and the new staging system.
Rakheja R; Ko JP; Friedman K
Semin Roentgenol; 2013 Oct; 48(4):308-22. PubMed ID: 24034263
[No Abstract] [Full Text] [Related]
20. The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.
Rankin S
Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S156-60. PubMed ID: 22186083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
